RUO‘ZENLog in
Stocks › Healthcare › ATRC

Atricure stockATRC

Atricure Inc · Nasdaq
$61.28
−6.49% on the day
close Nov 5, 2026
What is happening with the stock

Atricure trades at $61.28, 7.2% below its 52-week high (Nov 4, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +54.9% year to date, +89.6% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 23, 2027.

Closing price, 6 monthsdetailed chart in the terminal
25.3446.0166.6852-week high 66.02May 8, 2026Nov 5, 2026
Reported figurestrailing 12 months
🔒 Sector comparison, estimates and ratings are in the terminal

Ratings, candles, signals and the screener for ATRC — after you log in

Open the terminal
From 52-week high−7.2%
High66.02 Nov 4, 2026
vs 50-day avg+8.2%
vs 200-day avg+59.1%
Year to date+54.9%
12 months+89.6%
Dividend yieldnone
EarningsFeb 23
Market cap$3.1B
Chart patterncup with handle
Exchange · sinceNasdaq · 2005

Frequently asked questions about Atricure

What is the Atricure stock price?

At the close on Nov 5, 2026: $61.28 (−6.49% on the day). 52-week high: $66.02 on Nov 4, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.

When does Atricure report earnings?

The next quarterly report is on Feb 23, 2027. Last quarter, earnings per share changed +900% year over year, revenue +15%.

Does Atricure pay dividends?

No, Atricure does not pay dividends.

Where does Atricure trade and how to buy it?

Ticker ATRC, exchange Nasdaq, listed since 2005. You can buy it through a broker with access to US exchanges.

Should I buy Atricure now?

We do not give buy or sell advice. Ratings, the detailed chart and signals for ATRC are in the terminal after you log in.

Similar stocks

More on ATRC

Included in lists